AXT Inc (AXTI) Stock Price & How to Invest

AXT Inc. is a small-cap manufacturer of compound semiconductor substrates and specialty materials used in optoelectronics and high-frequency wireless applications. The company's products include indium phosphide (InP) substrates for high-speed optical communications and lasers, gallium arsenide (GaAs) substrates for wireless and optoelectronic devices, and germanium (Ge) substrates for solar cells and infrared optics. The company also produces high-purity germanium and other specialty raw materials.

AXT's manufacturing is concentrated in China, which has been both an opportunity (cost competitiveness, proximity to Chinese photonics and wireless customers) and a risk (geopolitical exposure, US-China trade restrictions, China's export controls on gallium and germanium). The company has been working through recent export control regimes and customer mix shifts. Headquartered in Fremont, California with operations primarily in China. Morris Young is co-founder and CEO.

2026 has been a breakout year. After 2025 revenue of about $88 million and a net loss of about $21 million, Q2 2026 revenue jumped to about $47.6 million (up about 165% year over year) and AXT earned about $11 million, with EPS of $0.19 against a $0.07 estimate. Trailing twelve-month revenue reached about $126 million and turned slightly profitable. The stock rose from a 52-week low near $4.35 to a high near $143 before settling around $54 in mid-October, and AXTI joined the S&P SmallCap 600 in September 2026. The balance sheet now shows about $417 million of cash against about $102 million of debt. Q3 2026 results are scheduled for October 29, with consensus near $66 million of revenue and EPS of $0.31.

China manufacturing concentration creates geopolitical and trade-policy risk, and China export controls and US export restrictions create a complex compliance environment. Customer concentration in specific niches. Cyclical end markets (optics, wireless) affect revenue. Valuation risk is now significant: at about 28 times trailing sales and about 24 times 2027 consensus EPS, the price assumes revenue roughly quintuples from 2025 to 2027, and the stock fell about 23% in the month to 2026-10-16. Working capital is also a watch item, with rising inventory and negative free cash flow even as earnings turned positive.

5 analysts publish price targets on AXTI, averaging $91.60 against a $51.47 price as of October 2026, or +78.0%. The published targets run from $55.00 to $125.00, a wide spread, and the ratings split 4 buy, 1 hold, 0 sell. Over the last six months there have been 3 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full AXTI forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on AXT Inc. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Indium phosphide for AI data center optics. InP substrates are the foundation for high-speed laser diodes used in data center optical interconnects (100G, 400G, 800G, 1.6T transceivers). The most optimistic published target, $125.00, assumes this works close to its best case.

The case against. China manufacturing concentration creates geopolitical and trade-policy risk, and China export controls and US export restrictions create a complex compliance environment. The most pessimistic target, $55.00, is roughly what AXTI is worth if this bites instead.

Read the full bull and bear case on AXTI, including what would have to change to break either one. Walnut is not an investment adviser.

No. AXT Inc (AXTI) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see AXT Inc's investor relations page or your broker.

• Market cap: ~$3.5 billion
• Revenue (TTM): ~$126 million (Q2 up ~165% YoY)
• Revenue (Q2 2026): ~$47.6 million
• Net income (TTM): ~$4 million (Q2 2026: ~$11 million)
• EPS (TTM / 2027 est.): ~$0.04 / ~$2.25
• P/E (forward): ~24x (trailing not meaningful)
• Price to sales: ~28x
• Cash / debt: ~$417 million / ~$102 million
• Dividend yield: None

AXT's valuation has moved from option value to a growth multiple: about 28 times trailing sales and about 24 times forward earnings, with trailing P/E not meaningful on near-zero TTM profit. The case rests on consensus for revenue of about $218 million in 2026 and about $461 million in 2027 as InP demand from AI data center optics scales. Q3 2026 results on October 29 (consensus about $66 million of revenue and $0.31 EPS) are the next check on that ramp.

These are the investment theses AXTI naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to AXTI: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get AXTI exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so AXTI sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where AXTI fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

AXT (AXTI) has moved from a near-breakeven micro-cap to a roughly $3.5 billion small-cap whose valuation now assumes InP substrate revenue keeps scaling with the AI optical-interconnect cycle. Q2 2026 delivered the first real proof, with revenue of about $48 million and a return to profit, but at about 28 times trailing sales and after a 23% drop in the past month, it behaves as a high-volatility, China-policy-exposed satellite position several steps upstream of NVIDIA in the AI supply chain rather than a core semiconductor holding.

Whether AXTI is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AXTI a buy or a sell?, and where the stock could go from here in the AXTI stock forecast.

For income investors, whether AXTI pays a dividend and how the payout looks is covered in does AXTI pay a dividend? And to weigh AXTI against a peer, read the full side-by-side comparisons: AXTI vs NVDA and AXTI vs AMD.